Voxelotor

This medication, also known as Oxbryta, is utilized for the treatment of sickle cell disease in adults and children aged 4 and older. It stands out as the first hemoglobin oxygen-affinity modulator, marking a significant advancement in the medical field. Its primary function is to increase hemoglobin's affinity for oxygen, thus reducing the sickling of red blood cells.